Tag: Pharma

Claims of Pharma PAC contributions to Sanders, Warren overblown

Robert F. Kennedy Jr., President Trump’s nominee for health secretary, made a bold accusation last week during his

FDA takes action ahead of Trump, pharma CEOs on RFK Jr.: D.C. Diagnosis

The latest edition of D.C. Diagnosis from STAT's web newsletter is buzzing with updates on the FDA's recent

Does PBM Expansion Into Pharma Further Risk Anti-Competitive Behaviors

Pharmacy benefit managers (PBMs) have been under intense scrutiny in recent years, with concerns about their business practices

D.C. Diagnosis: Latest on budget talks, Pharma ok with RFK Jr.?

The ongoing budget talks in Congress have left behind two critical health and medicine issues: the Affordable Care

Pharma not lobbying against RFK Jr. for Trump’s HHS secretary

The controversy surrounding Robert F. Kennedy Jr.’s nomination to lead the Department of Health and Human Services in

The Loss in Revenue to Pharma from Medicare Price Negotiation

The Cato Institute recently hosted a forum in May featuring a discussion on the effects of Medicare price